Titre:
  • Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.
Auteur:Vermorken, Jan Baptist; Remenar, Eva; van Herpen, C M L; Gorlia, Thierry; Mesia, Ricard; Degardin, Marian; Stewart, J; Jelic, Svetislav; Betka, Jan; Preiss, Joachim H; Van Den Weyngaert, Danielle; Awada, Ahmad; Cupissol, Didier; Kienzer, Heinz R; Rey, Augustin; Desaunois, Isabelle; Bernier, J; Lefebvre, Jean-Louis; EORTC 24971/TAX 323 Study Group,
Informations sur la publication:The New England journal of medicine, 357, 17, page (1695-1704)
Statut de publication:Publié, 2007-10
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Carcinoma, Squamous Cell -- drug therapy
Carcinoma, Squamous Cell -- radiotherapy
Carcinoma, Squamous Cell -- surgery
Cisplatin -- administration & dosage
Combined Modality Therapy
Disease-Free Survival
Female
Fluorouracil -- administration & dosage
Head and Neck Neoplasms -- drug therapy
Head and Neck Neoplasms -- radiotherapy
Head and Neck Neoplasms -- surgery
Humans
Male
Middle Aged
Neoplasm Staging
Radiotherapy -- adverse effects
Survival Analysis
Taxoids -- administration & dosage
Note générale:Clinical Trial, Phase III
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0028-4793
info:doi/10.1056/NEJMoa071028
info:pii/357/17/1695
info:scp/35548966042
info:pmid/17960012